Published in Lab Law Weekly, April 27th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Danish Medicines Agency.
Report 1: Danish Medecines Agency -- The CHMP1 Pharmacovigilance Working Party has considered the safety of gadolinium-containing MRI contrast agents. The Committee has concluded that recommendations on the use of these contrast agents should be amended for patients with impaired renal function.
Report 2: A recent analysis of data from the North American Antiepileptic Drug Registry in the U.S. (NAAED) suggests an increased risk of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.